Objective To investigate the efficacy of oXiris-endotoxin adsorption technique in the treatment of end-stage renal disease (ESRD) complicated with sepsis. Methods A total of 41 patients with ESRD complicated with sepsis who were hospitalized in the First Affiliated Hospital of Henan University of Science and Technology from January 1, 2021 to July 30, 2023 were enrolled. Among these patients, 22 are in the oXiris filter treatment group, and the other 19 patietns are in the group treated by continuous veno-venous hemofiltration (CVVH) combined with Hemoperfusion (HP). In-hospital mortality, length of stay in ICU, length of mechanical ventilation, length of continuous renal replacement therapy, number of patients with mechanical ventilation, number of filter and Acute Physiology and Chronic Health Evaluation (Apache-II), Norepinephrine (NE) dosage and laboratory test results at the beginning of and after hemopurification treatment were compared between the two groups. Results The mechanical ventilation duration in oXiris group was significantly shorter than that in CVVH+HP group (Z= -3.749, P=0.001). After treatment, APACHE-II (t=-4.481, P=0.001), NE dosage (t=-2.036, P=0.049), C-reactive protein, procalcitonin (Z=-2.850, P=0.004), interleukin-6 (Z=-2.512, P=0.012) in oXiris group were significantly lower than those in CVVH+HP group. Conclusion oXiris-endotoxin adsorption technique can effectively reduce inflammatory factors in ESRD patients with sepsis, and it’s effect is better than CVVH+HP treatment; which has good value of clinical application.
HUANG He-Ben
,
WANG Jun-Xia
,
WANG Jun-Xia Jun-Rui
,
GUO Qiong-Qiong
,
LI Wen-Tian
,
SUN Yu-Xin
. Clinical observation of oXiris-endotoxin adsorption technique in the treatment of ESRD patients with [J]. Chinese Journal of Blood Purification, 2024
, 23(04)
: 250
-255
.
DOI: 10.3969/j.issn.1671-4091.2024.04.003
[1]Arulkumaran N, Annear NM, Singer M. Patients with end-stage renal disease admitted to the intensive care unit: systematic review[J].British journal of anaesthesia, 2013, 110(1):13-20
[2]Saran, Rajiv et al.US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States[J].American journal of kidney diseases : the official journal of the National Kidney Foundation, 2019, 73(3 Suppl 1):7-8
[3]Sakhuja A, Nanchal RS, Gupta S, et al.Trends and Outcomes of Severe Sepsis in Patients on Maintenance Dialysis.?Am J Nephrol[J].American journal of nephrology, 2016, 43(2):97-103
[4]Kumbar L, Yee J.Current Concepts in Hemodialysis Vascular Access Infections[J].Advances in chronic kidney disease, 2019, 26(1):16-22
[5]Locham S, Naazie I, Canner J, Siracuse J, Al-Nouri O, Malas M.Incidence and risk factors of sepsis in hemodialysis patients in the United States[J].Journal of vascular surgery, 2021, 73(3):1016-1021
[6]Bou Chebl R, Tamim H, Abou Dagher G, et al.Sepsis in end-stage?renal disease patients: are they at an increased risk of mortality?[J].Annals of medicine, 2021, 53(1):1737-1743
[7]Collins AJ, Foley RN, Chavers B, et al. US Renal Data System 2013 Annual Data Report[J].American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, 63(1):7-7
[8]Fysaraki, Maria et al.Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis[J].International journal of medical sciences, 2013, 10(12):1632-1638
[9]Matsumoto H, Ogura H, Shimizu K, et al.The clinical importance of a cytokine network in the acute phase of sepsis[J].Scientific reports, 2018, 8(1):13995-13995
[10]Cecconi M, Evans L, Levy M, Rhodes A.Sepsis and septic shock[J].Lancet (London, England), 2018, 392(10141):75-87
[11]Singer M, Deutschman CS, Seymour CW, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J].JAMA, 2016, 315(8):801-810
[12]Bahtouee M, Eghbali SS, Maleki N, Rastgou V, Motamed N.Acute Physiology and Chronic Health Evaluation II score for the assessment of mortality prediction in the intensive care unit: a single-centre study from Iran[J].Nursing in critical care, 2019, 24(6):375-380
[13]Schuetz P, Beishuizen A, Broyles M, et al.Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use[J].Clinical chemistry and laboratory medicine, 2019, 57(9):1308-1318
[14]吴鹏, 邬娇.床旁检测、-和在儿童急性上呼吸道感染疾病诊断中的应用分析[J].检验医学与临床, 2016, 13(09):1222-1223
[15]Zhang YY, Ning BT.Signaling pathways and intervention therapies in sepsis[J].Signal transduction and targeted therapy, 2021, 6(1):407-407
[16]Abas?yan?k MF, Wolfe K, Van Phan H, et al.Ultrasensitive digital quantification of cytokines and bacteria predicts septic shock outcomes[J].Nature communications, 2020, 11(1):2607-2607
[17]Venet F, Monneret G.Advances in the understanding and treatment of sepsis-induced immunosuppression[J].Nature reviews. Nephrology, 2018, 14(2):121-137
[18]Abou Dagher G, Harmouche E, Jabbour E, Bachir R, Zebian D, Bou Chebl R.Sepsis in hemodialysis patients[J].BMC emergency medicine, 2015, 15(30):-
[19]Broman ME, Hansson F, Vincent JL, Bodelsson M.Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study[J].PLoS One, 2019, 14(8):-
[20]Zhang H, Zhu G, Yan L, Lu Y, Fang Q, Shao F.The absorbing filter Oxiris in severe coronavirus disease 2019 patients: A case series[J].Artificial organs, 2020, 44(12):1296-1302
[21]Feng J, Zhang S, Ai T, et al.Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: A pilot randomized controlled trial[J].The International journal of artificial organs, 2022, 45(10):801-808
[22]Zhou Y, Wu C, Ouyang L, et al.Application of oXiris-continuous hemofiltration adsorption in patients with sepsis and septic shock: A single-centre experience in China[J].Frontiers in public health, 2022, 10(1012998):-
[23]Huang X, Zhang F, Zhong Y.Comment on: Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis[J].Critical care (London, England), 2023, 27(1):305-305
[24]Hiraiwa T, Moriyama K, Matsumoto K, et al.In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters[J].Blood purification, 2020, 49(3):295-301
[25]孙仁华 & 刘景全.重症患者连续性肾脏替代治疗时抗生素剂量调整[J].现代实用医学, 2016, 23(08):981-984
[26]Schwindenhammer V, Girardot T, Chaulier K, et al.oXiris? Use in Septic Shock: Experience of Two French Centres[J].Blood Purif, 2019, 47(Suppl 3):1-7
